All Stories

  1. DTH : A nonparametric test for homogeneity of multivariate dispersions
  2. Ranked severe maternal morbidity index for population-level surveillance at delivery hospitalization based on hospital discharge data
  3. Impact of Experimental Bias on Compositional Analysis of Microbiome Data
  4. Integrative analysis of microbial 16S gene and shotgun metagenomic sequencing data improves statistical efficiency
  5. What Can We Learn about the Bias of Microbiome Studies from Analyzing Data from Mock Communities?
  6. Testing microbiome associations with survival times at both the community and individual taxon levels
  7. LOCOM: A logistic regression model for testing differential abundance in compositional microbiome data with false discovery rate control
  8. Associations between microbial communities and key chemical constituents in U.S. domestic moist snuff
  9. Efficient estimation of indirect effects in case‐control studies using a unified likelihood framework
  10. LOCOM: A logistic regression model for testing differential abundance in compositional microbiome data with false discovery rate control
  11. A rarefaction-based extension of the LDM for testing presence–absence associations in the microbiome
  12. Multisample adjusted U-statistics that account for confounding covariates
  13. PhredEM: a phred-score-informed genotype-calling approach for next-generation sequencing studies
  14. Restoring the Duality between Principal Components of a Distance Matrix and Linear Combinations of Predictors, with Application to Studies of the Microbiome
  15. Testing Rare-Variant Association without Calling Genotypes Allows for Systematic Differences in Sequencing between Cases and Controls
  16. PhredEM: A Phred-Score-Informed Genotype-Calling Approach for Next-Generation Sequencing Studies
  17. Utilizing Population Controls in Rare-Variant Case-Parent Association Tests
  18. Robust Regression Analysis of Copy Number Variation Data based on a Univariate Score
  19. Effects of maternal smokeless tobacco use on selected pregnancy outcomes in Alaska Native women: a case–control study
  20. Risk Assessment and Evaluation of Predictions
  21. A Permutation Procedure to Correct for Confounders in Case-Control Studies, Including Tests of Rare Variation
  22. Stratification-Score Matching Improves Correction for Confounding by Population Stratification in Case-Control Association Studies
  23. Age-associated DNA methylation in pediatric populations
  24. California Very Preterm Birth Study: design and characteristics of the population- and biospecimen bank-based nested case-control study
  25. Maternal smokeless tobacco use in Alaska Native women and singleton infant birth size
  26. Control for Confounding in Case-Control Studies Using the Stratification Score, a Retrospective Balancing Score
  27. A weighted accumulation test for associating rare genetic variation with quantitative phenotypes
  28. Inverse Probability of Censoring Weighted U-statistics for Right-Censored Data with an Application to Testing Hypotheses
  29. Percentage of Gestational Diabetes Mellitus Attributable to Overweight and Obesity
  30. Microdeletions of 3q29 Confer High Risk for Schizophrenia
  31. Late Preterm Birth and Risk of Developing Asthma
  32. Percentage of Gestational Diabetes Mellitus Attributable to Overweight and Obesity
  33. Score-based adjustment for confounding by population stratification in genetic association studies
  34. Fast and Robust Association Tests for Untyped SNPs in Case-Control Studies
  35. SNPs in CAST are associated with Parkinson disease: A confirmation study
  36. A novel haplotype-sharing approach for genome-wide case-control association studies implicates the calpastatin gene in Parkinson's disease
  37. A Regression-based Association Test for Case-control Studies that Uses Inferred Ancestral Haplotype Similarity
  38. Effect of population stratification on the identification of significant single-nucleotide polymorphisms in genome-wide association studies
  39. Genome-wide association analysis of rheumatoid arthritis data via haplotype sharing
  40. MALDI-TOF mass spectrometry as a tool for differentiation of invasive and noninvasiveStreptococcus pyogenesisolates
  41. A Signed-Rank Test for Clustered Data
  42. Response to Lee et al.
  43. Robust estimation and testing of haplotype effects in case-control studies
  44. A Simple and Improved Correction for Population Stratification in Case-Control Studies
  45. Statistical Models for Haplotype Sharing in Case-Parent Trio Data
  46. Inference on haplotype/disease association using parent-affected-child data: the projection conditional on parental haplotypes method
  47. Association mapping via a class of haplotype-sharing statistics
  48. Simple methods for assessing haplotype-environment interactions in case-only and case-control studies
  49. Genetic Studies of a Cluster of Acute Lymphoblastic Leukemia Cases in Churchill County, Nevada
  50. Investigating Childhood Leukemia in Churchill County, Nevada
  51. Comment
  52. Improved association analyses of disease subtypes in case-parent triads
  53. Rank-Sum Tests for Clustered Data
  54. Cross-Sectional Study
  55. Genetic Association Analysis Using Data from Triads and Unrelated Subjects
  56. Genetic Analysis Workshop 14: microsatellite and single-nucleotide polymorphism marker loci for genome-wide scans
  57. Robust testing of haplotype/disease association
  58. Standardization and denoising algorithms for mass spectra to classify whole-organism bacterial specimens
  59. An empirical bayes adjustment to increase the sensitivity of detecting differentially expressed genes in microarray experiments
  60. Comparison of prospective and retrospective methods for haplotype inference in case-control studies
  61. How special is a 'special' interval: modeling departure from length-biased sampling in renewal processes
  62. Inference on Haplotype Effects in Case-Control Studies Using Unphased Genotype Data
  63. Random error and undercounting in birth defects surveillance data: Implications for inference
  64. Performance Characteristics of a New Less Sensitive HIV-1 Enzyme Immunoassay for Use in Estimating HIV Seroincidence
  65. HFE genotype and transferrin saturation in the United States
  66. Estimation of Stage Occupation Probabilities in Multistage Models
  67. Marginal Analyses of Clustered Data When Cluster Size Is Informative
  68. Informative Missingness in Genetic Association Studies: Case-Parent Designs
  69. Bootstrap calibration of TRANSMIT for informative missingness of parental genotype data
  70. Marginal Analyses of Multistage Data
  71. Estimation of Integrated Transition Hazards and Stage Occupation Probabilities for Non-Markov Systems Under Dependent Censoring
  72. HIV Seroincidence Among Patients at Clinics for Sexually Transmitted Diseases in Nine Cities in the United States
  73. HIV seroconverting donors delay their return: screening test implications
  74. Subtype-specific Transmission Probabilities for Human Immunodeficiency Virus Type 1 among Injecting Drug Users in Bangkok, Thailand
  75. Midrank unification of rank tests for exact, tied, and censored data
  76. Analysis of Dynamic Cohort Data
  77. Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers
  78. Evaluation of a Sensitive/Less-Sensitive Testing Algorithm Using the 3A11-LS Assay for Detecting Recent HIV Seroconversion among Individuals with HIV-1 Subtype B or E Infection in Thailand
  79. Nonparametric Maximum Likelihood Estimation for Competing Risks Survival Data Subject to Interval Censoring and Truncation
  80. Accounting for Unmeasured Population Substructure in Case-Control Studies of Genetic Association Using a Novel Latent-Class Model
  81. Marginal estimation for multi-stage models: waiting time distributions and competing risks analyses
  82. Nonparametric Estimation for the Three-Stage Irreversible Illness-Death Model
  83. The S-U algorithm for missing data problems
  84. Conditional and Unconditional Categorical Regression Models with Missing Covariates
  85. Repeat Screening for HIV: When to Test and Why
  86. Estimating the Extent of Tracking in Interval-Censored Chain-Of-Events Data
  87. Validating Marker-Based Incidence Estimates in Repeatedly Screened Populations
  88. Detection of Early HIV Infection and Estimation of Incidence Using a Sensitive/Less-Sensitive Enzyme Immunoassay Testing Strategy at Anonymous Counseling and Testing Sites in San Francisco
  89. Hold everything! Holding policies for protecting plasma supplies
  90. Fitting Semi-Markov Models to Interval-Censored Data with Unknown Initiation Times
  91. Discrete-Time Nonparametric Estimation for Semi-Markov Models of Chain-of-Events Data Subject to Interval Censoring and Truncation
  92. Kaplan–Meier representation of competing risk estimates
  93. HIV Seroincidence and Risk Factors Among Patients Repeatedly Tested for HIV Attending Sexually Transmitted Disease Clinics in the United States, 1991 to 1996
  94. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis
  95. New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes
  96. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  97. Inference Based on Imputed Failure Times for the Proportional Hazards Model with Interval-Censored Data
  98. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure
  99. Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'lvoire
  100. Steady-state calculation of the risk of HIV infection from transfusion of screened blood from repeat donors
  101. Markov Chains With Measurement Error: Estimating the `True' Course of a Marker of the Progression of Human Immunodeficiency Virus Disease
  102. Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States
  103. Upper and Lower Bound Distributions that Give Simultaneous Confidence Intervals for Quantiles
  104. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors
  105. Modelling the female-to-male per-act HIV transmission probability in an emerging epidemic in Asia
  106. Estimation of Incidence of HIV Infection Using Cross-Sectional Marker Surveys
  107. Direct oral questions to blood donors: the impact on screening for human immunodeficiency virus
  108. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group
  109. Probability of female-to-male transmission of HIV-1 in Thailand
  110. Conditional Regression Analysis of the Exposure-Disease Odds Ratio Using Known Probability-of-Exposure Values
  111. [Backcalculation of HIV Infection Rates]: Comment
  112. Inferences About Exposure-Disease Associations Using Probability-of-Exposure Information
  113. Inferences About Exposure-Disease Associations Using Probability-of- Exposure Information
  114. HIV Infection among Patients in U.S. Acute Care Hospitals
  115. Continued Fraction Representation for Expected Cell Counts of a 2 x 2 Table: A Rapid and Exact Method for Conditional Maximum Likelihood Estimation
  116. Sample size determination for pair-matched case-control studies where the goal is interval estimation of the odds ratio
  117. Critical phenomena in randomly stirred fluids: Correlation functions, equation of motion, and crossover behavior
  118. Critical phenomena in randomly stirred fluids
  119. Modification of nonequilibrium fluctuations by interaction with surfaces